Clinical Trial

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to investigate the role of uNK cells and the association with prednisolone.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-04-03; most recent amendment 2025-03-19.
Status change: Not Yet Recruiting → Recruiting 2019-07-29
Trial Details
NCT Number NCT03902912
Lead Sponsor Chinese University of Hong Kong
Conditions Recurrent Miscarriage
Enrollment 84 participants
Start Date 2019-07-30
Primary Completion 2027-04-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-21